DE69534407D1 - Dihydro-2,3-Benzodiazepinderivate - Google Patents

Dihydro-2,3-Benzodiazepinderivate

Info

Publication number
DE69534407D1
DE69534407D1 DE69534407T DE69534407T DE69534407D1 DE 69534407 D1 DE69534407 D1 DE 69534407D1 DE 69534407 T DE69534407 T DE 69534407T DE 69534407 T DE69534407 T DE 69534407T DE 69534407 D1 DE69534407 D1 DE 69534407D1
Authority
DE
Germany
Prior art keywords
phenyl
alkyl
dihydro
benzodiazepine derivatives
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534407T
Other languages
English (en)
Other versions
DE69534407T2 (de
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Nancy Kay Harn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69534407D1 publication Critical patent/DE69534407D1/de
Application granted granted Critical
Publication of DE69534407T2 publication Critical patent/DE69534407T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
DE69534407T 1994-08-31 1995-08-30 Dihydro-2,3-Benzodiazepinderivate Expired - Lifetime DE69534407T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US413029 1989-09-27
US29864594A 1994-08-31 1994-08-31
US298645 1994-08-31
US41302995A 1995-03-28 1995-03-28

Publications (2)

Publication Number Publication Date
DE69534407D1 true DE69534407D1 (de) 2005-09-29
DE69534407T2 DE69534407T2 (de) 2006-03-16

Family

ID=26970798

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69525342T Expired - Lifetime DE69525342T2 (de) 1994-08-31 1995-08-30 Dihydro-2,3-benzodiazepinderivate
DE69534407T Expired - Lifetime DE69534407T2 (de) 1994-08-31 1995-08-30 Dihydro-2,3-Benzodiazepinderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69525342T Expired - Lifetime DE69525342T2 (de) 1994-08-31 1995-08-30 Dihydro-2,3-benzodiazepinderivate

Country Status (13)

Country Link
US (1) US5795886A (de)
EP (3) EP0771198B1 (de)
JP (1) JP4131987B2 (de)
AT (2) ATE212994T1 (de)
CA (1) CA2198751C (de)
DE (2) DE69525342T2 (de)
DK (2) DK0771198T3 (de)
ES (2) ES2170804T3 (de)
FI (1) FI113049B (de)
HK (1) HK1013794A1 (de)
NZ (1) NZ292417A (de)
PT (2) PT1157992E (de)
WO (1) WO1996006606A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA972746B (en) * 1996-04-04 1998-10-09 Egyt Gyogyszervegyeszeti Gyar Novel 2,3-benzodiazepine derivatives
HUP9701325A1 (hu) * 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
HU9803014D0 (en) * 1998-12-23 1999-02-01 Egyt Gyogyszervegyeszeti Gyar Novel phtalazine derivatives, process for their production and pharmaceutical compositions containing the same
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
FI970833A0 (fi) 1997-02-27
HK1013794A1 (en) 1999-09-10
NZ292417A (en) 1998-09-24
EP1157992A1 (de) 2001-11-28
DE69525342D1 (de) 2002-03-21
CA2198751C (en) 2006-07-11
EP0771198B1 (de) 2002-02-06
EP1157992B1 (de) 2005-08-24
JP4131987B2 (ja) 2008-08-13
PT771198E (pt) 2002-06-28
FI970833A (fi) 1997-02-27
ES2170804T3 (es) 2002-08-16
DK0771198T3 (da) 2002-04-22
DE69534407T2 (de) 2006-03-16
JPH10505066A (ja) 1998-05-19
PT1157992E (pt) 2005-10-31
DK1157992T3 (da) 2005-10-24
ATE212994T1 (de) 2002-02-15
WO1996006606A1 (en) 1996-03-07
EP0771198A4 (de) 1997-05-28
EP1593683A2 (de) 2005-11-09
DE69525342T2 (de) 2002-11-07
EP1593683A3 (de) 2006-10-25
AU689639B2 (en) 1998-04-02
EP0771198A1 (de) 1997-05-07
ES2244524T3 (es) 2005-12-16
AU3418695A (en) 1996-03-22
ATE302779T1 (de) 2005-09-15
FI113049B (fi) 2004-02-27
CA2198751A1 (en) 1996-03-07
US5795886A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
DE69425162T2 (de) 4,5-diaryloxazol-derivate
MX9800577A (es) Derivados de 4,5-diaril oxazol.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
WO1998028282A3 (en) OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
DK0598359T3 (da) Hypoglykæmiske dihydrochalconderivater
NO983900D0 (no) Mellomprodukt for fremstilling av terapeutisk aktive forbindelser
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
WO2001062705A3 (en) Aminoalcohol derivatives
PE46699A1 (es) Compuesto derivado de indol
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
DE69534407D1 (de) Dihydro-2,3-Benzodiazepinderivate
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
ATE259800T1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
DE60323862D1 (de) 1,2,4-triazolderivat, verfahren zu dessen herstellung, und dieses enthaltende pharmazeutische zusammensetzung
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
WO1996025933A3 (en) Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks

Legal Events

Date Code Title Description
8364 No opposition during term of opposition